News | April 22, 2026
Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
The conclave brought together key stakeholders from across the assisted living ecosystem
The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
Subscribe To Our Newsletter & Stay Updated
